A Study of the Pharmacokinetics and Safety of CS0159 in Subjects With Hepatic Injury

Clinical trial NCT06888115 · COMPLETED

Trial details

NCT number: NCT06888115
Sponsor: Cascade Pharmaceuticals, Inc
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Primary Biliary Cholangitis

Start date: 2025-03-13
Primary completion: 2025-05-29
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.